An update from Novo Nordisk ( ($NVO) ) is now available. Novo Nordisk reported full-year 2025 results on 3 February 2026, with sales rising 6% in D......

Novo Nordisk ( ($NVO) ) just unveiled an update. On 3 February 2026, Novo Nordisk reported that in 2025 its sales rose 10% and operating profit inc......

Shares of Novo Nordisk ($NVO) are tanking today after the drugmaker warned that its sales are likely to decline this year. This is due to increasin......

Novo Nordisk ( ($NVO) ) has shared an announcement. On 2 February 2026, Novo Nordisk reported headline phase 3 results from its REIMAGINE 2 trial s......

In a report released today, Matthew Weston from UBS maintained a Hold rating on Novo Nordisk, with a price target of DKK390.00. According to TipRan......

In a report released on January 30, David Evans from Kepler Capital maintained a Buy rating on Novo Nordisk, with a price target of DKK430.00. The ......

U.S. stocks ended the week lower as pressure from rates and commodities weighed on risk appetite. The Dow Jones Industrial Average (DJIA) fell 0.36......

Novo Nordisk ( ($NVO) ) has fallen by -7.11%. Read on to learn why. Novo Nordisk shares slipped 7.11% over the past week as investors weighed the c......

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk today and set a price target of DKK350.00. According to TipRanks, Vosser......

The pharma giants are fighting for market share. ...